Trading of Spago Nanomedical shares on Nasdaq First North Growth market starts today
Commencing today, Spago Nanomedical AB (publ) shares are traded at the Nasdaq First North Growth Market under the ticker “SPAGO”.
“Facilitation of healthcare and saving lives should always be a good investment. At Spago Nanomedical we are committed to improving treatment and diagnostics of life-threatening diseases as we continue to build our business. The listing at Nasdaq First North Gorwth Market is a stepping stone for continued value creation for our owners and eventually for patients with cancer. It marks the beginning of the next chapter of Spago Nanomedical”, says CEO Mats Hansen.
For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, firstname.lastname@example.org.
Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of solid tumors. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, see www.spagonanomedical.se.
FNCA Sweden AB is the Certified Adviser of the company, +46 8 528 00 399, email@example.com.